Jeffrey E Rubnitz
Overview
Explore the profile of Jeffrey E Rubnitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
170
Citations
6679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hashmi S, Bodea J, Patni T, Angel S, Bhakta N, Jeha S, et al.
JAMA Netw Open
. 2024 Feb;
7(2):e2355727.
PMID: 38363571
Importance: COVID-19 in pediatric patients with acute lymphoblastic leukemia or lymphoma (ALL/LLy) has not been described in detail and may affect chemotherapy administration and long-term outcomes. Objective: To describe the...
12.
Umeda M, Ma J, Westover T, Ni Y, Song G, Maciaszek J, et al.
Nat Genet
. 2024 Jan;
56(2):281-293.
PMID: 38212634
Recent studies on pediatric acute myeloid leukemia (pAML) have revealed pediatric-specific driver alterations, many of which are underrepresented in the current classification schemas. To comprehensively define the genomic landscape of...
13.
Barajas J, Rasouli M, Umeda M, Hiltenbrand R, Abdelhamed S, Mohnani R, et al.
Blood
. 2023 Oct;
143(7):619-630.
PMID: 37890156
UBTF tandem duplications (UBTF-TDs) have recently emerged as a recurrent alteration in pediatric and adult acute myeloid leukemia (AML). UBTF-TD leukemias are characterized by a poor response to conventional chemotherapy...
14.
Khanlari M, Wang W, Liu Y, Wang L, Rubnitz J, Dixon S, et al.
Haematologica
. 2023 Sep;
109(3):994-999.
PMID: 37767572
No abstract available.
15.
Hoshitsuki K, Zhou Y, Miller A, Choi J, Swanson H, Bhakta N, et al.
Leukemia
. 2023 Aug;
37(9):1782-1791.
PMID: 37543655
Polyethylene glycol (PEG)-asparaginase (pegaspargase) is a key agent in chemotherapy for acute lymphoblastic leukemia (ALL), but recipients frequently experience allergic reactions. We hypothesized that by decreasing antibody-producing CD20-positive B cells,...
16.
Umeda M, Ma J, Westover T, Ni Y, Song G, Maciaszek J, et al.
Res Sq
. 2023 Jul;
PMID: 37398194
Recent studies on pediatric acute myeloid leukemia (pAML) have revealed pediatric-specific driver alterations, many of which are underrepresented in the current classification schemas. To comprehensively define the genomic landscape of...
17.
Karol S, Coustan-Smith E, Pounds S, Wang L, Inaba H, Ribeiro R, et al.
Blood Adv
. 2023 Apr;
7(14):3651-3657.
PMID: 37058475
The prognostic significance of bone marrow minimal residual disease (MRD) in pediatric patients with acute myeloid leukemia (AML) is well characterized, but the impact of blood MRD is not known....
18.
van Weelderen R, Klein K, Harrison C, Jiang Y, Abrahamsson J, Arad-Cohen N, et al.
J Clin Oncol
. 2023 Mar;
41(16):2963-2974.
PMID: 36996387
Purpose: A previous study by the International Berlin-Frankfurt-Münster Study Group (I-BFM-SG) on childhood -rearranged (-r) AML demonstrated the prognostic value of the fusion partner. This I-BFM-SG study investigated the value...
19.
Christakopoulos G, Walker K, Smith J, Takemoto C, Zheng Y, Pui C, et al.
Cancer
. 2023 Mar;
129(12):1873-1884.
PMID: 36943896
Background: Hyperleukocytosis in patients with acute myeloid leukemia (AML) has been associated with worse outcomes. For cytoreduction, leukapheresis has been used but its clinical utility is unknown, and low-dose cytarabine...
20.
Kamens J, Nance S, Koss C, Xu B, Cotton A, Lam J, et al.
Nat Commun
. 2023 Mar;
14(1):1297.
PMID: 36894563
No abstract available.